Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 1.00 |
| ▸ | CTNNB1 | P35222 | 1/20 | 1.00 |
| ▸ | MGLL | Q99685 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.52 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.52 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26111924 | 0.98 | BCL9 (0.97) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| Butyric Acid SCHEMBL2307779 | 0.94 | BCL9 (0.88) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL28215337 | 0.91 | BCL9 (0.83) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL10728358 | 0.91 | BCL9 (0.83) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL27348135 | 0.91 | BCL9 (0.83) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL30694347 | 0.91 | BCL9 (0.83) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL828974 | 0.90 | BCL9 (0.82) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL957930 | 0.90 | BCL9 (0.81) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| SCHEMBL1400174 | 0.89 | BCL9 (0.80) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 | |
| P-Nitrophenol SCHEMBL28859114 | 0.89 | BCL9 (0.79) | BCL9CTNNB1MGLLKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1890 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | claimed |
| CN-119286820-A | Novel esterase and encoding gene and novel application thereof | 常州大学 | 2025-01-10 | — | — | CN | claimed |
| EP-3696264-B1 | COMPOSITIONS AND METHODS COMPRISING A LIPOLYTIC ENZYME VARIANT | DANISCO US INC (US) | 2023-06-28 | — | — | EP | claimed |
| CN-111057691-B | Novel GDSL family lipid hydrolase EII-3 and encoding gene and application thereof | 自然资源部第二海洋研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-108251401-B | Lipase and application thereof | 丰益(上海)生物技术研发中心有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-107189955-B | Novel deep-sea thermostable alkaline esterase and application thereof | 自然资源部第二海洋研究所 | 2022-07-15 | — | — | CN | claimed |
| CN-114736887-A | Use of carboxylesterase | 上海威高医疗技术发展有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114694776-A | Refining of pueraria flower isoflavone and research method of lipid-lowering effect thereof | 长春职业技术学院 | 2022-07-01 | — | — | CN | claimed |
| CN-110004125-B | Novel alkali-resistant and organic solvent-resistant esterase from marine bacteria and application thereof | 自然资源部第二海洋研究所 | 2022-05-20 | — | — | CN | claimed |
| CN-113087833-B | Polymer-supported artificial catalysis triad catalyst and preparation method and application thereof | 湖北大学 | 2022-04-01 | — | — | CN | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| EP-0897942-B1 | A method of crosslinking collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC INC (US) | 2004-03-10 | — | — | EP | claimed |
| US-6166184-A | Process for making a bioprosthetic device | MEDTRONIC INC. (US) | 2000-12-26 | — | — | US | claimed |
| EP-0897942-A1 | A method of crosslinking collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC, INC. (US) | 1999-02-24 | — | — | EP | claimed |
| CN-1161962-A | Sulphonic-acid-amide derivative | KONO PHARMACEUTICAL IND K K (JP) | 1997-10-15 | — | — | CN | claimed |
| US-5188937-A | Binding of signal antibody to antigen | BECTON, DICKINSON AND COMPANY (US) | 1993-02-23 | — | — | US | claimed |
| US-5164515-A | Chemical compounds | WENDSTONE CHEMICALS PLC (GB) | 1992-11-17 | — | — | US | claimed |
| EP-0268452-B1 | NOVEL HYDROLASE AND METHOD OF PRODUCTION | GENENCOR, INC. (US) | 1992-01-22 | — | — | EP | claimed |
| EP-0268452-A2 | Novel hydrolase and method of production | GENENCOR, INC. (US) | 1988-05-25 | — | — | EP | claimed |
| EP-0239354-A2 | 2,2-Dinitrophenylethane derivatives and their application as protecting compounds | Wendstone Chemicals P.L.C. (GB) | 1987-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | BCHE, LIPE, ACHE | BCL9 2500/4885CTNNB1 3981/4885MGLL 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.